Aptamer Group PLC
Research Aptamer Group PLC (APTA) on Bullrun: market cap GBX 1.13B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAPTA
- ExchangeLSE
- CountryUnited Kingdom
- SectorHealthcare
- IndustryBiotechnology
- CurrencyGBX
- Market capGBX 1.13B
- Financial periodFY2025
- RevenueGBP 1.20M
- Revenue growth39.9%
- Net income-GBP 2.42M
- Free cash flow-GBP 2.04M
- Gross margin48.1%
Valuation Snapshot
latest market cap is GBX 1.13B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | GBP 1.20M | -GBP 2.42M | -GBP 2.04M | 48.1% | 0 | GBP 1.06M | GBP 491.00K | GBP 1.38M |
| FY2024 | GBP 860.00K | -GBP 2.96M | -GBP 2.41M | 29.1% | -0.01 | GBP 870.00K | GBP 817.00K | GBP 887.00K |
| FY2023 | GBP 1.75M | -GBP 7.84M | -GBP 6.09M | 20.5% | -0.11 | GBP 234.00K | GBP 1.08M | GBP 304.00K |
| FY2022 | GBP 4.04M | -GBP 2.09M | -GBP 2.79M | 66.5% | -0.03 | GBP 6.69M | GBP 1.31M | GBP 8.05M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-27 | GBX 1.13B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 GBX.
About Aptamer Group PLC
Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers, which can bind to target molecules. Its platform is used in research reagent and analytical, bioprocessing, diagnostic, cosmetic and consumer health, and therapeutic applications.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Aptamer Group PLC's market cap?
Aptamer Group PLC's market capitalization is GBX 1.13B.
What does Aptamer Group PLC do?
Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers, which can bind to target molecules. Its platform is used in research reagent and analytical, bioprocessing, diagnostic, cosmetic and consumer health, and therapeutic applications. The company serves pharmaceutical, diagnostic, and bioprocessing companies.